Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Iovanace Biotherapeutics (IOVA) PT Lowered to $45 at Chardan Capital Markets
-
Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Chardan Capital Markets on BLA Delay
-
Iovanace Biotherapeutics (IOVA) PT Lowered to $50 at Chardan Capital Markets on Delay
-
Iovanace Biotherapeutics (IOVA) PT Raised to $33 at Chardan Capital Markets
-
Iovanace Biotherapeutics (IOVA) PT Raised to $30 at Chardan Capital Markets
-
Iovanace Biotherapeutics (IOVA) PT Maintained at $30 at Chardan Capital Markets; 'Market Misunderstandings' Offer 'Buying Opportunity Ahead of Data'
-
Iovanace Biotherapeutics (IOVA) PT Raised to $30 at Chardan Capital Markets, Top Pick for 2018
-
Iovance Biotherapeutics, Inc. Announces Closing of $57.5 Million Common Stock Public Offering
-
Iovance Biotherapeutics (IOVA) Prices 7.692M Share Common Offering at $6.50/Sh
-
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $50 Million of Common Stock
-
Iovanace Biotherapeutics (IOVA): Fast Track Status Validates Regulatory Path - Chardan

